MMP Proteins Could Spot Oral Cancer Early

Mouth cancer is becoming more common around the world. Over the past ten years, daily habits and the environment have driven up the number of cases. This type of cancer is called oral squamous cell carcinoma. Finding it early can save lives. When diagnosis happens too late, the chances of survival go down.

Scientists study a group of enzymes known as matrix metalloproteinases, or MMPs. These enzymes need zinc and calcium to work. They break down the support structure that holds body tissues in place. In oral cancer, MMPs help tumors grow, invade nearby areas, and spread. Researchers knew MMPs were involved, but they were not sure how well they predict patient outcomes.

A team examined all 23 human MMP genes. They searched two large genetic databases, the Gene Expression Omnibus and The Cancer Genome Atlas. From this data, they picked out six MMP genes that appeared different in oral tissue. The genes were MMP-1, MMP-10, MMP-3, MMP-12, MMP-13, and MMP-9. The team tested whether these genes could forecast survival using charts, survival curves, and prediction models.

The computer model worked best when the six MMP genes were combined with the standard cancer staging system called TNM. The analysis also tied these enzymes to changes in how cancer cells use energy and multiply. This hints that MMPs play a role in tumor progression.

To verify the computer findings, the researchers tested blood samples from oral cancer patients in South India. They measured MMP-1, MMP-10, and MMP-9 using a lab technique called ELISA. All three proteins showed much higher levels in patients compared with healthy people. The results were statistically strong, with p-values under 0.0001 for two proteins and 0.0002 for the third. The findings indicate that high blood levels of MMP-1, MMP-10, and MMP-9 may work as simple blood-based warning signs for oral cancer in this South Indian group.